ZURICH, Switzerland – Nanoflex Robotics AG, a developer of magnetically controlled telerobotic systems for endovascular intervention, announced today that it has been selected for funding under the European Innovation Council (EIC) Accelerator, one of Europe’s most competitive and prestigious programs for breakthrough, high-impact innovation. The award comprises €12.5 million in blended financing, made up of a €2.5 million grant and a €10 million equity investment from the EIC Fund.
In this round, only 38 companies across 16 EU and associated countries were selected, chosen from about one thousand applications. Nanoflex Robotics was one of just four Swiss companies selected – and the only medical technology company among them.
Nanoflex Robotics is building a next-generation robotics platform designed to overcome the structural barriers that limit access to life-saving endovascular procedures, most visibly in stroke. Using magnetic navigation to steer ultra-flexible guidewires through the vasculature, the platform makes complex procedures faster and safer, and lays the groundwork for bringing specialist care to the patient through remote, teleoperated intervention. The funding will enable Nanoflex Robotics to complete clinical validation toward CE marking in Europe and bring the first commercial version of its platform to market.
“This funding is a major step toward expanding clinical validation of the Nanoflex Robotics platform, and a fantastic endorsement of our team, our technology, and the business we’re building. Our unique electromagnetically controlled robotic platform navigates blood vessels faster and more accurately than today’s devices. We are honored to have the EIC’s support — a powerful affirmation of our mission to close the gap in access to treatment between rural and urban communities.” said Matt Curran, CEO of Nanoflex Robotics.
About Nanoflex Robotics
Nanoflex Robotics is building a next-generation telerobotics platform designed to expand access to time-critical endovascular procedures. Spun out of ETH Zurich, the company combines advanced magnetic navigation technology with ultra-flexible steerable guidewires and catheters to give physicians greater precision, control, and dexterity during complex interventions. By enabling safer and more accurate procedures, the platform aims to improve patient outcomes and broaden access to specialized vascular care. To learn more, please visit: www.nanoflexrobotics.com